SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
45567
Lv1
30 积分
2022-09-27 加入
最近求助
最近应助
互助留言
Exploring Molecular Mechanisms in the Second-Line Treatment of Biliary Tract Malignant Tumors
13天前
已关闭
New Horizons for Precision Medicine in Biliary Tract Cancers
4个月前
已完结
Second-line therapies in advanced biliary tract cancers
5个月前
已完结
Circulating tumor cells in gastric cancer: developments and clinical applications
8个月前
已完结
Molecular Targets in Cholangiocarcinoma
8个月前
已完结
Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer
8个月前
已完结
Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer
9个月前
已完结
Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Interim results from the phase 2 study FIDES-01
9个月前
已关闭
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
9个月前
已完结
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
9个月前
已完结
没有进行任何应助
不需要啦【积分已退回】
13天前
查询失败【积分已退回】
10个月前
感谢
1年前
感谢
1年前
感谢
1年前
感谢
1年前
搜索错误【积分已退回】
1年前
感谢
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论